Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Local Metastatic Melanoma”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Not applicableLooking for participantsNCT06363591
What this trial is testing

WoW - Single- vs Two-staged Excisions of Thin Melanoma

Who this might be right for
Melanoma
Vastra Gotaland Region 2,486
Testing effectiveness (Phase 2)Study completedNCT00204594
What this trial is testing

Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28

Who this might be right for
Malignant Melanoma
University Hospital Tuebingen 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT01644591
What this trial is testing

Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Melanoma+1 more
M.D. Anderson Cancer Center 49
Early research (Phase 1)Ended earlyNCT01216436
What this trial is testing

Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Duke University 2
Early research (Phase 1)Study completedNCT01469455
What this trial is testing

DNA Repair Inhibitor & Irradiation on Melanoma

Who this might be right for
Local Metastatic Melanoma
DNA Therapeutics 27
Not applicableUnknownNCT04583605
What this trial is testing

The Aim of This Study is to Demonstrat That Vacuum-assisted Closure Versus Conventional Wound Closure Enables to Diminish Local Complications After Lymph Node Dissection in Patients With Metastatic Skin Tumors

Who this might be right for
MelanomaSkin CancerEpidermoid Carcinoma+2 more
Central Hospital, Nancy, France 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT00338377
What this trial is testing

Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 1,230
Early research (Phase 1)Ended earlyNCT04935229
What this trial is testing

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma in the Liver
TriSalus Life Sciences, Inc. 67
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00720031
What this trial is testing

Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones

Who this might be right for
Immunotherapy
Nantes University Hospital 16
Not applicableStudy completedNCT00049010
What this trial is testing

Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma

Who this might be right for
Melanoma (Skin)
Alliance for Clinical Trials in Oncology 314
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Looking for participantsNCT06727630
What this trial is testing

A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Zhuhai Yufan Biotechnologies Co., Ltd 40
Testing effectiveness (Phase 2)Study completedNCT03898908
What this trial is testing

Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain

Who this might be right for
Metastatic MelanomaBrain Metastases
Grupo Español Multidisciplinar de Melanoma 48
Testing effectiveness (Phase 2)Ended earlyNCT04221438
What this trial is testing

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Who this might be right for
Melanoma of Unknown PrimaryMetastatic Malignant Neoplasm in Lymph NodePathologic Stage IIIB Cutaneous Melanoma AJCC v8+3 more
ECOG-ACRIN Cancer Research Group 3
Testing effectiveness (Phase 2)Study completedNCT00004250
What this trial is testing

Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)Sarcoma
Memorial Sloan Kettering Cancer Center 35
Early research (Phase 1)Not Yet RecruitingNCT05903937
What this trial is testing

Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases

Who this might be right for
Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 6
Testing effectiveness (Phase 2)UnknownNCT03514901
What this trial is testing

To Evaluate the Efficacy Beyond Progression of Vemurafenib+Cobimetinib Associated With Local Treatment Compared to Second-line Treatment in Patients With BRAFV600+ Metastatic Melanoma in Focal Progression With First-line+Vemurafenib+Cobimetinib.

Who this might be right for
Melanoma MetastaticBRAF V600 Mutation
Intergruppo Melanoma Italiano 120
Early research (Phase 1)Not Yet RecruitingNCT07183852
What this trial is testing

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 18
Next Page